Frontiers in Oncology | Gynecological Oncology

Original Research

Published on 28 Nov 2023

Efficacy and toxicities of doxorubicin plus ifosfamide in the second-line treatment of uterine leiomyosarcoma

in Gynecological Oncology

Szu-Yun Niu
Lou Sun
Shih-Tien Hsu
Sheau-Feng Hwang
Chih-Ku Liu
Yu-Hsiang Shih
Ting-Fang Lu
Yen-Fu Chen
Li-Ching Lai
Pei-Lun Chang

Frontiers in Oncology

doi 10.3389/fonc.2023.1282596

2,278 views
1 citation

Original Research

Published on 28 Nov 2023

Mendelian randomization analysis to elucidate the causal relationship between small molecule metabolites and ovarian cancer risk

in Gynecological Oncology

Xin Chang
Shijia Liu
Lu Han

Frontiers in Oncology

doi 10.3389/fonc.2023.1291033

2,837 views
1 citation

Original Research

Published on 27 Nov 2023

Twenty-five-year mortality trends of four major histological subtypes of cervical cancer: a population-based study using the Osaka cancer registry data

in Gynecological Oncology

Naoko Komura
Seiji Mabuchi
Tomoyuki Sasano
Shoji Kamiura
Toshitaka Morishima
Isao Miyashiro

Frontiers in Oncology

doi 10.3389/fonc.2023.1233354

1,109 views

Case Report

Published on 27 Nov 2023

Case report: prolonged durable clinical benefit and low toxicity from combination endocrine therapy in a patient with recurrent endometrial carcinoma

in Gynecological Oncology

Joyce M. Cheng
Stephanie Gaillard
Anna L. Beavis
Tullia Rushton
Amanda N. Fader

Frontiers in Oncology

doi 10.3389/fonc.2023.1249370

1,681 views

Case Report

Published on 27 Nov 2023

Simultaneous occurrence of two distinct histotypes of ovarian endometriosis-associated cancer in bilateral ovaries: implications for monoclonal histogenesis from a case report

in Gynecological Oncology

Luyang Zhao
Yunyue Liu
Feng Liu
Xiangshu Jin
Jia Xu
Shuting Zhou
Yuanguang Meng
Aijun Liu
Weng Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1280529

1,532 views

Original Research

Published on 23 Nov 2023

AI-assisted system improves the work efficiency of cytologists via excluding cytology-negative slides and accelerating the slide interpretation

in Gynecological Oncology

Hui Du
Wenkui Dai
Qian Zhou
Changzhong Li
Shuai Cheng Li
Chun Wang
Jinlong Tang
Xiangchen Wu
Ruifang Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1290112

1,634 views
4 citations

Review

Published on 22 Nov 2023

Latest advances in the study of non-coding RNA-mediated circadian rhythm disorders causing endometrial cancer

in Gynecological Oncology

Ling-tao Zheng
Shao-rong Chen
Liang-yu Zhou
Qiao-yi Huang
Jia-ming Chen
Wei-hong Chen
Shu Lin
Qi-yang Shi

Frontiers in Oncology

doi 10.3389/fonc.2023.1277543

1,868 views
2 citations

Original Research

Published on 22 Nov 2023

Development of a combined model incorporating clinical characteristics and magnetic resonance imaging features to enhance the predictive value of a prognostic model for locally advanced cervical cancer

in Gynecological Oncology

Canyang Lin
Fengling Yang
Baoling Guo
Nan Xiao
Dongxia Liao
Pengfei Liu
Yunshan Jiang
Jiancheng Li
Xiaolei Ni

Frontiers in Oncology

doi 10.3389/fonc.2023.1284493

1,201 views

Mini Review

Published on 20 Nov 2023

Research progress on the premature ovarian failure caused by cisplatin therapy

in Gynecological Oncology

Zelin Li
Haodong Qi
Zhengyang Li
Yuxuan Bao
Kangping Yang
Qinghua Min

Frontiers in Oncology

doi 10.3389/fonc.2023.1276310

2,909 views
5 citations

Original Research

Published on 17 Nov 2023

Identifying clinical features and molecular characteristics of the endometrial clear cell carcinoma

in Gynecological Oncology

Yuhan Cai
Qin Han
Hongyan Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1286176

1,219 views
1 citation

Case Report

Published on 13 Nov 2023

Synchronous mucinous metaplasia and neoplasia of the female genital tract with both pulmonary metastases and STK11/KRAS gene mutations: a case report

in Gynecological Oncology

Ru Wang
Hao Yu
Ming Liu
Ting Hao
Xiangyu Wang
Lianbao Cao

Frontiers in Oncology

doi 10.3389/fonc.2023.1246821

1,472 views
3 citations

Methods

Published on 13 Nov 2023

Comparison of the survival outcomes of laparoscopic, abdominal and gasless laparoscopic radical hysterectomy for early-stage cervical cancer: trial protocol of a multicenter randomized controlled trial (LAGCC trial)

in Gynecological Oncology

Xiaoyan Tang
Shan Zhou
Xuyin Zhang
Keqin Hua
Yuan He
Ping Wang
Yincheng Teng
Weiwei Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1287697

1,593 views
1 citation

Review

Published on 10 Nov 2023

Tertiary lymphoid structures in gynecological cancers: prognostic role, methods for evaluating, antitumor immunity, and induction for therapy

in Gynecological Oncology

Ke Zhang
Xiao Xie
Shuang-Lin Zheng
Yuan-Run Deng
Dan Liao
Hai-Chen Yan
Xi Kang
Hui-Ping Jiang
Sui-Qun Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1276907

2,912 views
1 citation

Clinical Trial

Published on 09 Nov 2023

Outcomes of fertility preservation treatments in patients with endometrial cancer with different molecular classifications based on an NGS panel

in Gynecological Oncology

Yan Xu
Mingming Zhao
Li Zhang
Tianyou Wang
Bo Wang
Yu Xue
Zhiying Xu
Wenyu Shao
Xiaojun Chen
Chao Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1282356

2,255 views
4 citations

Original Research

Published on 08 Nov 2023

Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma

in Gynecological Oncology

Elena Mairinger
Michael Wessolly
Paul Buderath
Sabrina Borchert
Larissa Henrich
Pawel Mach
Julia Steinborn
Rainer Kimming
Bharat Jasani
Kurt Werner Schmid

Frontiers in Oncology

doi 10.3389/fonc.2023.1252700

1,619 views
1 citation

Editorial

Published on 01 Nov 2023

Editorial: Novel targets for ovarian cancer stem cells

in Gynecological Oncology

Yinu Wang
Livia E. Sima
Dongyu Jia
Guangyuan Zhao
Yaqi Zhang
Jia Xie

Frontiers in Oncology

doi 10.3389/fonc.2023.1325066

963 views

Navigation group

Articles

Efficacy and toxicities of doxorubicin plus ifosfamide in the second-line treatment of uterine leiomyosarcoma

Mendelian randomization analysis to elucidate the causal relationship between small molecule metabolites and ovarian cancer risk

Twenty-five-year mortality trends of four major histological subtypes of cervical cancer: a population-based study using the Osaka cancer registry data

Case report: prolonged durable clinical benefit and low toxicity from combination endocrine therapy in a patient with recurrent endometrial carcinoma

Simultaneous occurrence of two distinct histotypes of ovarian endometriosis-associated cancer in bilateral ovaries: implications for monoclonal histogenesis from a case report

AI-assisted system improves the work efficiency of cytologists via excluding cytology-negative slides and accelerating the slide interpretation

Latest advances in the study of non-coding RNA-mediated circadian rhythm disorders causing endometrial cancer

Development of a combined model incorporating clinical characteristics and magnetic resonance imaging features to enhance the predictive value of a prognostic model for locally advanced cervical cancer

Research progress on the premature ovarian failure caused by cisplatin therapy

Identifying clinical features and molecular characteristics of the endometrial clear cell carcinoma

Synchronous mucinous metaplasia and neoplasia of the female genital tract with both pulmonary metastases and STK11/KRAS gene mutations: a case report

Comparison of the survival outcomes of laparoscopic, abdominal and gasless laparoscopic radical hysterectomy for early-stage cervical cancer: trial protocol of a multicenter randomized controlled trial (LAGCC trial)

Tertiary lymphoid structures in gynecological cancers: prognostic role, methods for evaluating, antitumor immunity, and induction for therapy

Outcomes of fertility preservation treatments in patients with endometrial cancer with different molecular classifications based on an NGS panel

Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma

Editorial: Novel targets for ovarian cancer stem cells